Innovative Research, Inclusive Trials, and New Funding Drives Hope for People with Parkinson’s Disease

PhotoPharmics Secures $16 Million Investment Led by Kickstart to Fund Pivotal Clinical Trial for FDA Market Authorization

American Fork, UT. / November 15, 2023/ EINPresswire/ – PhotoPharmics, an innovator in Parkinson’s disease research and treatment, today announced the successful first close of a $16 million investment round. The investment round, led by Kickstart Fund, a venture capital firm based in Salt Lake City, marks a significant milestone in PhotoPharmics’ mission to revolutionize Parkinson’s disease treatment.– Read More…